<DOC>
	<DOC>NCT02176577</DOC>
	<brief_summary>The purpose of this study is to evaluate the Pharmacokinetics of Product 0405 in the Treatment of Atopic Dermatitis in Adolescent Subjects.</brief_summary>
	<brief_title>Study to Determine the Pharmacokinetics of Product 0405</brief_title>
	<detailed_description>Treament medication will be administered topically twice daily for 28 days.</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Clinical diagnosis of Atopic Dermatitis Good health with the exception of Atopic Dermatitis Percent body surface area minimums Subject who are nursing, pregnant or planning a pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>